Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Milano

Showing results (61-70 of 166) with videos related to

Pageof 17
Sort By:
Journal of Neuro-Oncology|August 20, 2011
Incidental brain lesions in children: to treat or not to treat?Amy-Lee Bredlau, Louis S Constine, Howard J Silberstein, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 31, 2009
Central thoracic lesions treated with hypofractionated stereotactic body radiotherapyMichael T Milano, Yuhchyau Chen, Alan W Katz, et al.
Cancer|January 10, 2015
Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphomaAmit K Chowdhry, Colin McHugh, Chunkit Fung, et al.
Seminars in Radiation Oncology|March 23, 2016
Dose-Response Model for Chest Wall Tolerance of Stereotactic Body Radiation TherapyFrank Kimsey, Jesse McKay, Jeffrey Gefter, et al.
Expert Review of Anticancer Therapy|November 5, 2015
The evolving role of radiotherapy in treatment of oligometastatic NSCLCDerek P Bergsma, Joseph K Salama, Deepinder P Singh, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 29, 2019
Immunotherapy with hypofractionated radiotherapy in metastatic non-small cell lung cancer: An analysis of the National Cancer DatabaseJames E Bates, Christopher G Morris, Michael T Milano, et al.
Cancer|July 9, 2004
Intensity-modulated radiotherapy and the InternetDavid A Schomas, Michael T Milano, John C Roeske, et al.
Neuro-Oncology|March 4, 2024
The role of radiotherapy in immunotherapy strategies in the central nervous systemMatthew Gallitto, Peter C Pan, Michael D Chan, et al.
International Journal of Radiation Oncology, Biology, Physics|September 20, 2005
Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcomeMichael T Milano, Ashesh B Jani, Karl J Farrey, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 19, 2019
Oligometastatic breast cancer treated with hypofractionated stereotactic radiotherapy: Some patients survive longer than a decadeMichael T Milano, Alan W Katz, Hong Zhang, et al.
Pageof 17

Showing results (61-70 of 166) with videos related to

Sort By:
Pageof 17
Journal of Neuro-Oncology|August 20, 2011
Incidental brain lesions in children: to treat or not to treat?Amy-Lee Bredlau, Louis S Constine, Howard J Silberstein, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 31, 2009
Central thoracic lesions treated with hypofractionated stereotactic body radiotherapyMichael T Milano, Yuhchyau Chen, Alan W Katz, et al.
Cancer|January 10, 2015
Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphomaAmit K Chowdhry, Colin McHugh, Chunkit Fung, et al.
Seminars in Radiation Oncology|March 23, 2016
Dose-Response Model for Chest Wall Tolerance of Stereotactic Body Radiation TherapyFrank Kimsey, Jesse McKay, Jeffrey Gefter, et al.
Expert Review of Anticancer Therapy|November 5, 2015
The evolving role of radiotherapy in treatment of oligometastatic NSCLCDerek P Bergsma, Joseph K Salama, Deepinder P Singh, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 29, 2019
Immunotherapy with hypofractionated radiotherapy in metastatic non-small cell lung cancer: An analysis of the National Cancer DatabaseJames E Bates, Christopher G Morris, Michael T Milano, et al.
Cancer|July 9, 2004
Intensity-modulated radiotherapy and the InternetDavid A Schomas, Michael T Milano, John C Roeske, et al.
Neuro-Oncology|March 4, 2024
The role of radiotherapy in immunotherapy strategies in the central nervous systemMatthew Gallitto, Peter C Pan, Michael D Chan, et al.
International Journal of Radiation Oncology, Biology, Physics|September 20, 2005
Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcomeMichael T Milano, Ashesh B Jani, Karl J Farrey, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 19, 2019
Oligometastatic breast cancer treated with hypofractionated stereotactic radiotherapy: Some patients survive longer than a decadeMichael T Milano, Alan W Katz, Hong Zhang, et al.
Pageof 17